journal article·2024-08-20

Polyaptamer-Driven Crystallization of Alendronate for Synergistic Osteoporosis Treatment through Osteoclastic Inhibition and Osteogenic Promotion

Xingsen Yang, Yu Fan, Junhao Liang, Runfeng Cao, Beibei Zhang, Jianhua Li, Zejuan Li, Shisheng He, Na Liu, Jianzhong Du, Yong Hu

ACS Nano· Volume 18· Issue 33
Publisher page

Abstract

Osteoclastic inhibition using antiresorptive bisphosphonates and osteogenic promotion using antisclerostin agents represent two distinct osteoporosis treatments in clinical practice, each individual treatment suffers from unsatisfactory therapeutic efficacy due to its indirect intervention in osteoclasis and promotion of osteogenesis simultaneously. Although this issue is anticipated to be resolved by drug synergism, a tempting carrier-free dual-medication nanoassembly remains elusive. Herein, we prepare such a nanoassembly made of antiresorptive alendronate (ALN) crystal and antisclerostin polyaptamer (Apt) via a nucleic acid-driven crystallization method. This nanoparticle can protect Apt from rapid nuclease degradation, avoid the high cytotoxicity of free ALN, and effectively concentrate in the cancellous bone by virtue of the bone-binding ability of DNA and ALN. More importantly, the acid microenvironment of cancellous bone triggers the disassociation of nanoparticles for sustained drug release, from which ALN inhibits the osteoclast-mediated bone resorption while Apt promotes osteogenic differentiation. Our work represents a pioneering demonstration of nucleic acid-driven crystallization of a bisphosphonate into a tempting carrier-free dual-medication nanoassembly. This inaugural advancement augments the antiosteoporosis efficacy through direct inhibition of osteoclasis and promotion of osteogenesis simultaneously and establishes a paradigm for profound understanding of the underlying synergistic antiosteoporosis mechanism of antiresorptive and antisclerostin components. It is envisioned that this study provides a highly generalizable strategy applicable to the tailoring of a diverse array of DNA-inorganic nanocomposites for targeted regulation of intricate pathological niches.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone health and treatments · Bone and Joint Diseases · Bone Metabolism and Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, Shanghai 201804, P. R. China

Department of Orthopedics, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai 200072, P. R. China

Department of Gynaecology and Obstetrics, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai 200434, P. R. China

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, P. R. China

2nd Physics Institute, University of Stuttgart, Stuttgart D-70569, Germany

Max Planck Institute for Solid State Research, Stuttgart D-70569, Germany

Funding

Shanghai Municipal Education Commission · National Natural Science Foundation of China · Tongji University · Shanghai International Scientific Collaboration Fund

References (45)

Show source-provided references
1. 10.1002/jbmr.228610.1002/jbmr.2286 ↗
2. 10.1056/NEJMcp151372410.1056/NEJMcp1513724 ↗
3. 10.1038/ncprheum097710.1038/ncprheum0977 ↗
4. 10.1016/S0140-6736(10)62349-510.1016/S0140-6736(10)62349-5 ↗
5. 10.1016/j.bone.2011.04.02210.1016/j.bone.2011.04.022 ↗
6. 10.1016/j.jconrel.2013.01.03210.1016/j.jconrel.2013.01.032 ↗
7. 10.1359/jbmr.1998.13.4.58110.1359/jbmr.1998.13.4.581 ↗
8. 10.1073/pnas.96.1.13310.1073/pnas.96.1.133 ↗
9. 10.1056/NEJMoa03089710.1056/NEJMoa030897 ↗
10. 10.1016/j.biomaterials.2014.03.06910.1016/j.biomaterials.2014.03.069 ↗
11. 10.1039/C5TB01956G10.1039/C5TB01956G ↗
12. 10.1039/C8TB03062F10.1039/C8TB03062F ↗
13. 10.1359/JBMR.04111410.1359/JBMR.041114 ↗
14. 10.1002/jcp.2646510.1002/jcp.26465 ↗
15. 10.1016/j.bone.2016.12.01210.1016/j.bone.2016.12.012 ↗
16. 10.1042/BJ2010109610.1042/BJ20101096 ↗
17. 10.1016/j.addr.2018.04.00710.1016/j.addr.2018.04.007 ↗
18. 10.1016/j.apsb.2022.01.01210.1016/j.apsb.2022.01.012 ↗
19. 10.7150/thno.6317710.7150/thno.63177 ↗
20. 10.1038/s41467-022-31997-810.1038/s41467-022-31997-8 ↗
21. 10.1016/j.nantod.2022.10152910.1016/j.nantod.2022.101529 ↗
22. 10.1126/science.154631110.1126/science.1546311 ↗
23. 10.1126/science.261.5126.128610.1126/science.261.5126.1286 ↗
24. 10.1002/anie.20140032310.1002/anie.201400323 ↗
25. 10.1021/acsnano.8b0649210.1021/acsnano.8b06492 ↗
26. 10.1002/adma.20200773810.1002/adma.202007738 ↗
27. 10.1021/acs.nanolett.1c0215010.1021/acs.nanolett.1c02150 ↗
28. 10.1016/j.biomaterials.2020.12034510.1016/j.biomaterials.2020.120345 ↗
29. 10.1016/j.bioactmat.2021.04.03810.1016/j.bioactmat.2021.04.038 ↗
30. 10.1002/advs.20230211910.1002/advs.202302119 ↗
31. 10.1016/j.nantod.2023.10196910.1016/j.nantod.2023.101969 ↗
32. 10.1016/S8756-3282(97)00270-610.1016/S8756-3282(97)00270-6 ↗
33. 10.1002/jbm.b.3083310.1002/jbm.b.30833 ↗
34. 10.1016/j.biomaterials.2009.04.01010.1016/j.biomaterials.2009.04.010 ↗
35. 10.1002/path.262810.1002/path.2628 ↗
36. 10.2147/DDDT.S12756810.2147/DDDT.S127568 ↗
37. 10.1359/jbmr.06070710.1359/jbmr.060707 ↗
38. 10.1021/bc034090j10.1021/bc034090j ↗
39. 10.1016/j.nantod.2023.10183810.1016/j.nantod.2023.101838 ↗
40. 10.1126/sciadv.adf332910.1126/sciadv.adf3329 ↗
41. 10.1021/acsnano.9b0024110.1021/acsnano.9b00241 ↗
42. 10.1186/s40364-017-0097-410.1186/s40364-017-0097-4 ↗
43. 10.1016/j.pmatsci.2020.10068610.1016/j.pmatsci.2020.100686 ↗
44. 10.1016/j.chempr.2022.04.00310.1016/j.chempr.2022.04.003 ↗
45. 10.34133/2021/980752010.34133/2021/9807520 ↗